Overview

Efficacy and Safety of Sirolimus to Vascular Anomalies

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of Sirolimus in complicated vascular anomalies in Chinese children
Phase:
N/A
Details
Lead Sponsor:
West China Hospital
Treatments:
Everolimus
Sirolimus